Trasylol
Trasylol Linked to Heart Attack in Heart Surgery Patients
Trasylol is a drug used to prevent excessive bleeding in patients undergoing coronary artery bypass graft (CABG) surgery. This dangerous drug can greatly increase the risk of heart attack, stroke and kidney failure.
Because Trasylol is administered during surgery, patients are unaware that they have been exposed to the drug's risks.
If you had a heart attack or stroke or suffered kidney damage after having bypass surgery, you should speak to a lawyer who understands the risk posed by Trasylol and other defective medications. Contact the Law Offices of J. Neal Rodgers, PLLC for a free initial consultation.
Documented Problems With Trasylol
- A January 26, 2006 report in The New England Journal of Medicine suggests that Trasylol administration may increase the risk for serious side-effects, including heart attack, stroke and kidney damage, among some patients undergoing CABG.
- Another published study suggests that patients receiving Trasylol may be at higher risk for kidney damage.
In March 2007, the FDA announced that Bayer Pharmaceuticals had revised the prescribing information for Trasylol (aprotinin). Thousands of patients were exposed to its risk prior to that date. If you suspect you were among them, please call our toll free number: 888-471-2637 or contact us by e-mail.
Attorney J. Neal Rodgers and his legal team will assess your case and advise you of your options. There is no charge for this service. We represent people harmed by dangerous drugs nationwide. You can rely on us for compassionate and responsive service and effective representation. Together, we will make them pay for the harm you have suffered.
